The CDA: Per-Shipment Customs Destination Certificates in Chile

1. Key takeaways

The CDA (Certificado de Destinación Aduanera, the customs destination certificate) is a per-shipment mandatory document for controlled medical devices entering Chile. Its legal basis is Ley N° 18.164, de 1982, Article 2, and Article 111(g) of the Sanitary Code makes explicit that the customs destination of devices is governed by that law. The ISP is the competent technical authority issuing the CDA nationwide. Without a valid CDA, the goods do not leave the port, regardless of what registration documents exist.

The point GRZAN must emphasize: holding the sanitary registration does not mean each shipment can clear customs. The registration certificate is the market access qualification; the CDA and the authorization of use and disposition are per-shipment formalities. Both are required before the goods can be released, and neither can substitute for the other. Companies that treat the certificate as the end of the regulatory journey discover, usually at the port, that it is only the beginning. The corrective action is always the same: schedule the per-shipment documents as first-class logistics milestones, with owners, lead times and contingency buffers, rather than as an afterthought delegated to the customs broker.

2. Legal basis

The following sources govern the CDA and its interaction with the registration regime:

• Regime of customs destination certificates for imported goods | Ley N° 18.164, de 1982 | 1982 | Article 2: establishes the customs destination certificate (CDA) regime.
• Sanitary Code of Chile (Código Sanitario) | DFL N° 725, de 1967 | Article 111(g) | the customs destination of such devices is governed by Ley N° 18.164, and their use and disposition must be authorized by the ISP.
• Regulation on the control of pharmaceutical products and medical devices | Decreto Supremo N° 825, de 1998 | August 21, 1999 | Article 27: the authorization of use and disposition; Article 25: the scope of verification for repeated imports of the same product.
• ISP filing and processing platform | GICONA | the CDA and the authorization of use and disposition are processed through the system.

3. Expert insights

Insight 1: the CDA is per-shipment, not one-time.

The registration certificate answers whether the product may enter the market; the CDA answers whether this particular shipment may enter the country. The two questions are legally separate, and Article 111(g) of the Sanitary Code lists them side by side precisely because neither absorbs the other. The most common corporate error is to book shipments the moment the certificate arrives, only to have the goods stranded at port because no CDA was filed. The stranded shipment then generates demurrage, storage charges and, for cold-chain products, genuine quality risk. Every import plan should carry an explicit CDA step with a named owner and a lead time measured in working days, not an assumption that the certificate covers it. The booking decision and the document decision belong to the same person, and the shipment calendar should show both.

Insight 2: the CDA must name a destination warehouse, and that warehouse must already be authorized.

The destination warehouse on the CDA must point to an authorized warehouse registered in the system. If the warehouse is not authorized, or the authorized address does not match the actual delivery address, the CDA cannot be issued. This chains warehouse authorization directly into the customs clearance step: a warehouse problem surfaces not at the warehouse but at the port, where it is most expensive. The practical consequence is that warehouse readiness must be verified before shipment booking, not after arrival, because there is no way to fix an unauthorized destination warehouse while the goods are already at anchor. Warehouse authorization therefore belongs on the same critical path as the shipment schedule, not on a parallel checklist.

Insight 3: Article 25 of Decreto Supremo N° 825, de 1998 creates room for simplification on repeated imports.

The provision states that for repeated imports of the same product, the scope of verification is limited to confirming that the product is the same certified product, unless the inclusion decree requires per-batch verification. This is a frequently overlooked cost-optimization clause. But the precondition for applying it is that the product information matches the registration exactly: any difference in model, packaging or manufacturer data can void the simplification and trigger fuller verification. Consistency between the commercial documents, the labels and the certificate is therefore not merely cosmetic; it is what keeps each shipment on the fast path. A version-controlled checklist comparing labels, commercial documents and the certificate catches the drift before it reaches the port.

Insight 4: port detention costs usually exceed the official registration fees.

Port demurrage, storage charges and cold-chain breakage risks routinely exceed the official fees of the registration itself (practical estimate). GRZAN plans projects so that the processing time for the CDA and the authorization of use and disposition is scheduled as an explicit logistics milestone, rather than treated as an incidental matter for the customs broker. The planning rule is simple: no vessel booking until the per-shipment document path is confirmed feasible, and no cold-chain shipment without a buffer for processing delays at both ends of the journey.

4. Practical recommendations

1. Schedule the CDA and the use-and-disposition authorization into the logistics milestones; do not treat them as incidental customs-broker tasks.
2. Confirm that the destination warehouse is authorized and that the address matches, to avoid a failed CDA application.
3. Keep the imported product information identical to the registration, so that the simplified verification of Article 25 can apply.
4. Reserve a processing time window for cold-chain products, so that temperature-sensitive goods are never detained at port.
5. Maintain a per-shipment ledger: CDA number, use-and-disposition authorization number, batch number, arrival date and release date.

5. Verification checklist

• □ It has been confirmed that every import shipment requires a CDA (Article 2 of Ley N° 18.164)
• □ The destination warehouse is authorized and its address matches the CDA
• □ The imported product information is identical to the registration content (Article 25 simplification can apply)
• □ The logistics milestones reserve time for the CDA and the authorization
• □ A per-shipment ledger exists (CDA number, authorization number, batch number, dates)

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers entering the Chilean market with end-to-end services covering the local license holder and importer setup, CDA and use-and-disposition processing for every shipment, and fee and budget planning under the current ISP arancel. Whether you need a customs-readiness review, a cost model for your product class, or hands-on filing support through GICONA, our regulatory team is ready to help. Contact us at info@grzanglobal.com.